Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials.

The findings suggested that while PD-L1 inhibitors combined with CT showed a trend toward OS improvement, this did not achieve statistical significance (HR = 0.829, 95% CI: 0.683-1.006; 95% PI: 0.236-2.916, I 2 = 0%) ( Table 2 ; Supplementary Figure 11A ).

also in 53,322 other papers